ChemInform Abstract: Neuropsychopharmacological Study on an Animal Model for Negative Symptom of Schizophrenia Induced by Repeated Phencyclidine Treatment

ChemInform November 28, 2000 DOI: 10.1002/chin.200048268 (opens in new tab)

Study at a glance

Characteristics	Peer reviewed

Abstract

AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology February 1, 2003 via PubMed
Phencyclidine/schizophrenia: one view toward the past, the other to the future. Schizophrenia Bulletin September 1, 2012 via PubMed
Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine. Annals of the New York Academy of Sciences November 1, 2006 via PubMed
Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochemistry International January 1, 2007 via PubMed
Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis. Methods and findings in experimental and clinical pharmacology May 1, 2007 via PubMed

Comments

No comments yet.

Study at a glance

Abstract

Related reading

Comments